Wedge Capital Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-52,425
Closed -$1.15M 618
2019
Q2
$1.15M Sell
52,425
-119,638
-70% -$2.2M 0.01% 330
2019
Q1
$2.78M Buy
172,063
+12,792
+8% +$198K 0.03% 277
2018
Q4
$2.34M Hold
159,271
0.03% 278
2018
Q3
$2.5M Buy
159,271
+13,000
+9% +$186K 0.02% 277
2018
Q2
$2.16M Buy
+146,271
New +$2.27M 0.02% 276

Other funds holding ZYME

Wedge Capital Management's ZYME Position: Q3 2019 in Review

Wedge Capital Management sold out of Zymeworks (ZYME) in Q3 2019, closing a stake of 52,425 shares — an estimated $1.15M sold.

Wedge Capital Management first reported a position in ZYME in Q2 2018 and held it in 5 quarters. The position peaked at $2.78M in Q1 2019. 74 funds tracked by Wall St. Rank hold ZYME as of Q3 2019.

  • Wedge Capital Management reported no remaining Zymeworks position as of Q3 2019 after selling out during the quarter.
  • Wedge Capital Management sold 52,425 Zymeworks shares in Q3 2019, an estimated $1.15M.
  • Wedge Capital Management first reported a position in Zymeworks in Q2 2018 and held it in 5 quarters.
  • Wedge Capital Management's Zymeworks position peaked at $2.78M in Q1 2019.
  • 74 funds tracked by Wall St. Rank held Zymeworks as of Q3 2019.

Based on Wedge Capital Management's 13F filing for Q3 2019, filed 1 Nov 2019.